Coherus BioSciences (CHRS) Short Interest Ratio & Short Volume $1.07 -0.03 (-2.73%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.10 +0.02 (+2.34%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Coherus BioSciences Short Interest DataCoherus BioSciences (CHRS) has a short interest of 30.90 million shares. This marks a 3.73% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.2, indicating that it would take 6.2 days of the average trading volume of 1.92 million shares to cover all short positions.Current Short Interest30,900,000 sharesPrevious Short Interest29,790,000 sharesChange Vs. Previous Month+3.73%Dollar Volume Sold Short$36.46 millionShort Interest Ratio6.2 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares115,890,000 sharesPercentage of Shares Shorted26.66%Today's Trading Volume1,548,317 sharesAverage Trading Volume1,919,848 sharesToday's Volume Vs. Average81% Short Selling Coherus BioSciences? Sign up to receive the latest short interest report for Coherus BioSciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCHRS Short Interest Over TimeCHRS Days to Cover Over TimeCHRS Percentage of Float Shorted Over Time Coherus BioSciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202530,900,000 shares $36.46 million +3.7%N/A6.2 $1.18 1/15/202529,790,000 shares $43.49 million -3.0%N/A6 $1.46 12/31/202430,720,000 shares $42.39 million -1.1%N/A6.2 $1.38 12/15/202431,070,000 shares $50.02 million +1.1%N/A6.1 $1.61 11/30/202430,720,000 shares $37.48 million -7.0%N/A6 $1.22 11/15/202433,040,000 shares $24.58 million +4.9%N/A11.7 $0.74 10/31/202431,510,000 shares $23.47 million +5.6%N/A12.6 $0.75 10/15/202429,850,000 shares $27.17 million +6.8%N/A13.4 $0.91 9/30/202427,960,000 shares $29.08 million +11.4%N/A13 $1.04 9/15/202425,090,000 shares $32.62 million -0.2%N/A12.6 $1.30 Get the Latest News and Ratings for CHRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coherus BioSciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/202425,150,000 shares $34.96 million +4.8%N/A14.7 $1.39 8/15/202424,010,000 shares $37.22 million +6.0%N/A13.6 $1.55 7/31/202422,660,000 shares $34.90 million -1.6%N/A13.1 $1.54 7/15/202423,020,000 shares $37.98 million -0.1%N/A14 $1.65 6/30/202423,040,000 shares $39.86 million +3.8%N/A13.8 $1.73 6/15/202422,200,000 shares $37.52 million +0.6%N/A13.2 $1.69 5/31/202422,060,000 shares $40.15 million +1.3%N/A11.4 $1.82 5/15/202421,780,000 shares $47.48 million +0.4%N/A9.9 $2.18 4/30/202421,690,000 shares $42.51 million +0.7%N/A9.4 $1.96 4/15/202421,530,000 shares $47.37 million -8.2%N/A7.6 $2.20 3/31/202423,450,000 shares $56.05 million -9.5%N/A6.2 $2.39 3/15/202425,910,000 shares $57.52 million +7.1%N/A4.5 $2.22 2/29/202424,200,000 shares $55.18 million -4.4%N/A4.1 $2.28 2/15/202425,320,000 shares $72.16 million -10.0%N/A4.3 $2.85 1/31/202428,130,000 shares $60.48 million +2.6%N/A4.1 $2.15 1/15/202427,430,000 shares $70.50 million +13.2%N/A3.8 $2.57 12/31/202324,230,000 shares $80.69 million +1.9%N/A3.9 $3.33 12/15/202323,770,000 shares $51.58 million +10.8%N/A4.5 $2.17 11/30/202321,460,000 shares $45.71 million -1.1%N/A4.9 $2.13 11/15/202321,690,000 shares $39.04 million +9.3%N/A5.1 $1.80 10/31/202319,840,000 shares $66.46 million +6.0%N/A5.3 $3.35 10/15/202318,720,000 shares $71.32 million +6.4%N/A7 $3.81 9/30/202317,600,000 shares $65.82 million +21.1%N/A6.1 $3.74 9/15/202314,530,000 shares $71.49 million -7.2%N/A4.9 $4.92 8/31/202315,650,000 shares $83.41 million -0.3%N/A4.8 $5.33 8/15/202315,700,000 shares $70.18 million +16.7%N/A4.6 $4.47 7/31/202313,450,000 shares $64.83 million +6.9%N/A3.5 $4.82 7/15/202312,580,000 shares $51.07 million -16.4%N/A3.7 $4.06 6/30/202315,040,000 shares $64.22 million +15.4%N/A4.8 $4.27 6/15/202313,030,000 shares $70.23 million +0.2%N/A4.7 $5.39Your trading day could end at 11 AM (Ad)What do you usually do between 9:35 AM and 11:00 AM? Catch up on emails? Attend a meeting? Maybe grab a coffee? For me, it's become the most important part of my trading day. 85 minutes. That's usually all it takes. Set up at 9:35 AM… Check back at 11:00 AM. And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake. Sounds too simple, doesn't it?Tap this link and see the complete breakdown. 5/31/202313,010,000 shares $53.21 million +9.3%N/A6.5 $4.09 5/15/202311,900,000 shares $58.19 million +12.9%N/A7.7 $4.89 4/30/202310,540,000 shares $76.20 million -4.1%N/A9.9 $7.23 4/15/202310,990,000 shares $86.60 million -7.3%N/A11.1 $7.88 3/31/202311,850,000 shares $81.05 million -1.7%N/A11.2 $6.84 3/15/202312,050,000 shares $77.00 million +22.5%N/A9.6 $6.39 2/28/20239,840,000 shares $66.62 million +0.8%N/A8 $6.77 2/15/20239,760,000 shares $77.01 million +2.3%13.4%8.5 $7.89 1/31/20239,540,000 shares $80.90 million -6.2%13.1%7.7 $8.48 1/15/202310,170,000 shares $106.28 million +2.1%14.0%8.1 $10.45 12/30/20229,960,000 shares $78.88 million +2.9%13.7%8 $7.92 12/15/20229,680,000 shares $71.15 million -4.4%13.3%9.2 $7.35 11/30/202210,130,000 shares $69.49 million +1.5%13.9%10 $6.86 11/15/20229,980,000 shares $79.44 million +7.1%13.7%9.2 $7.96 10/31/20229,320,000 shares $81.08 million +0.3%12.8%9 $8.70 10/15/20229,290,000 shares $76.92 million -3.4%12.8%8.6 $8.28 9/30/20229,620,000 shares $92.45 million +2.3%13.2%8.9 $9.61 9/15/20229,400,000 shares $98.98 million -1.2%12.9%8.5 $10.53 8/31/20229,510,000 shares $106.32 million -8.6%13.1%8.6 $11.18 8/15/202210,400,000 shares $144.25 million -1.8%14.3%9.8 $13.87 7/31/202210,590,000 shares $89.70 million +7.5%14.6%9.5 $8.47 7/15/20229,850,000 shares $78.50 million -10.4%13.6%9.2 $7.97 6/30/202210,990,000 shares $79.57 million +13.1%15.2%10.4 $7.24 6/15/20229,720,000 shares $58.22 million -4.6%13.4%9.4 $5.99 5/31/202210,190,000 shares $74.79 million +0.8%14.1%10.8 $7.34 5/15/202210,110,000 shares $80.37 million +16.2%14.0%11.1 $7.95 4/30/20228,700,000 shares $78.65 million +13.7%12.0%9.8 $9.04 4/15/20227,650,000 shares $85.99 million +0.1%10.6%8.7 $11.24 3/31/20227,640,000 shares $98.63 million +9.0%10.6%8.6 $12.91 3/15/20227,010,000 shares $87.91 million -1.3%9.7%8.1 $12.54 2/28/20227,100,000 shares $83.71 million -5.2%9.9%8.2 $11.79 2/15/20227,490,000 shares $98.87 million +13.8%10.4%8.6 $13.20 1/31/20226,580,000 shares $81.33 million -4.1%9.2%8.3 $12.36 1/15/20226,860,000 shares $95.35 million -3.7%9.6%9.7 $13.90 12/31/20217,120,000 shares $113.64 million +4.4%9.9%11.4 $15.96 12/15/20216,820,000 shares $117.24 million -4.5%9.5%10.6 $17.19 11/30/20217,140,000 shares $132.59 million +1.4%9.9%11.2 $18.57 11/15/20217,040,000 shares $133.20 million -6.3%9.8%10.9 $18.92 10/29/20217,510,000 shares $125.64 million -0.1%10.5%10.9 $16.73 10/15/20217,520,000 shares $127.84 million +1.5%10.5%11.5 $17.00 9/30/20217,410,000 shares $119.08 million -13.4%10.4%10.7 $16.07 9/15/20218,560,000 shares $135.16 million -11.9%12.0%12.9 $15.79 8/31/20219,720,000 shares $155.33 million +5.4%13.7%15.1 $15.98 8/13/20219,220,000 shares $128.43 million -1.3%13.0%13.5 $13.93 7/30/20219,340,000 shares $121.89 million +0.2%13.3%13.3 $13.05 7/15/20219,320,000 shares $122.37 million -2.0%13.2%12.4 $13.13 6/30/20219,510,000 shares $131.52 million -1.9%13.5%12.1 $13.83 6/15/20219,690,000 shares $136.73 million -3.2%13.8%11.1 $14.11 5/28/202110,010,000 shares $131.73 million -5.3%14.1%11.1 $13.16 5/14/202110,570,000 shares $146.82 million -5.4%N/A10 $13.89Your trading day could end at 11 AM (Ad)What do you usually do between 9:35 AM and 11:00 AM? Catch up on emails? Attend a meeting? Maybe grab a coffee? For me, it's become the most important part of my trading day. 85 minutes. That's usually all it takes. Set up at 9:35 AM… Check back at 11:00 AM. And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake. Sounds too simple, doesn't it?Tap this link and see the complete breakdown. 4/30/202111,170,000 shares $164.20 million -16.8%16.4%10.3 $14.70 4/15/202113,420,000 shares $186.00 million -3.0%19.7%10.2 $13.86 3/31/202113,840,000 shares $199.99 million +1.9%20.3%10.2 $14.45 3/15/202113,580,000 shares $220.68 million +1.2%19.9%10 $16.25 2/26/202113,420,000 shares $204.66 million +2.6%19.7%10.2 $15.25 2/12/202113,080,000 shares $246.17 million -2.3%19.4%11.5 $18.82 1/29/202113,390,000 shares $259.77 million -11.3%19.8%12.2 $19.40 1/15/202115,100,000 shares $271.65 million -2.5%22.4%15.2 $17.99 12/31/202015,490,000 shares $272.16 million +6.1%22.9%17.6 $17.57 12/15/202014,600,000 shares $265.28 million -3.9%21.6%17.2 $18.17 11/30/202015,190,000 shares $282.84 million -3.6%22.5%17.2 $18.62 11/15/202015,760,000 shares $281.16 million -3.1%23.3%17.8 $17.84 10/30/202016,260,000 shares $278.86 million -3.0%24.1%17.9 $17.15 10/15/202016,770,000 shares $306.56 million -5.6%25.1%17.4 $18.28 9/30/202017,760,000 shares $325.72 million -5.9%26.5%18.4 $18.34 9/15/202018,870,000 shares $353.06 million +1.6%28.5%18.7 $18.71 8/31/202018,580,000 shares $352.46 million +3.2%28.1%17.4 $18.97 8/14/202018,010,000 shares $343.45 million -3.3%27.5%12.4 $19.07 7/31/202018,630,000 shares $327.70 million -3.8%28.5%12.3 $17.59 7/15/202019,370,000 shares $337.43 million +2.4%29.8%12.7 $17.42 6/30/202018,920,000 shares $327.88 million +3.4%29.1%10.6 $17.33 6/15/202018,290,000 shares $305.26 million +18.6%28.2%10.3 $16.69 5/29/202015,420,000 shares $281.42 million +10.0%23.8%8.4 $18.25 5/15/202014,020,000 shares $233.01 million +3.8%21.7%8.7 $16.62 4/30/202013,510,000 shares $224.27 million +26.7%20.9%8.9 $16.60 4/15/202010,660,000 shares $154.46 million -3.0%16.5%7.2 $14.49 3/31/202010,990,000 shares $190.46 million -5.4%17.0%8.9 $17.33 3/13/202011,618,200 shares $194.02 million -1.5%18.1%9.1 $16.70 2/28/202011,800,000 shares $167.91 million +1.5%18.3%11.1 $14.23 CHRS Short Interest - Frequently Asked Questions What is Coherus BioSciences' current short interest? Short interest is the volume of Coherus BioSciences shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 30,900,000 shares of CHRS short. Learn More on Coherus BioSciences' current short interest. What is a good short interest ratio for Coherus BioSciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CHRS shares currently have a short interest ratio of 6.0. Learn More on Coherus BioSciences's short interest ratio. Which institutional investors are shorting Coherus BioSciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Coherus BioSciences: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Coherus BioSciences' short interest increasing or decreasing? Coherus BioSciences saw a increase in short interest in January. As of January 31st, there was short interest totaling 30,900,000 shares, an increase of 3.7% from the previous total of 29,790,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Coherus BioSciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Coherus BioSciences: Autolus Therapeutics plc (3.42%), Valneva SE (0.05%), Xeris Biopharma Holdings, Inc. (7.04%), Tectonic Therapeutic (13.84%), MeiraGTx Holdings plc (2.66%), Mineralys Therapeutics, Inc. (7.89%), Entrada Therapeutics, Inc. (7.68%), Cartesian Therapeutics, Inc. (22.85%), Humacyte, Inc. (23.04%), Arcturus Therapeutics Holdings Inc. (18.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Coherus BioSciences stock? Short selling CHRS is an investing strategy that aims to generate trading profit from Coherus BioSciences as its price is falling. CHRS shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Coherus BioSciences? A short squeeze for Coherus BioSciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CHRS, which in turn drives the price of the stock up even further. How often is Coherus BioSciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHRS, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies AUTL Short Interest Data VALN Short Interest Data XERS Short Interest Data TECX Short Interest Data MGTX Short Interest Data MLYS Short Interest Data TRDA Short Interest Data RNAC Short Interest Data HUMA Short Interest Data ARCT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CHRS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coherus BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coherus BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
